Cargando…
ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells
Hepatocellular carcinoma (HCC) is the third leading cause of death due to cancer worldwide with over 500,000 people affected annually. Although chemotherapy has been widely used to treat patients with HCC, alternate modalities to specifically deliver therapeutic cargos to cancer cells have been soug...
Autores principales: | Yu, Ge, Li, Huan, Yang, Shuanghui, Wen, Jianguo, Niu, Junqi, Zu, Youli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726709/ https://www.ncbi.nlm.nih.gov/pubmed/26808385 http://dx.doi.org/10.1371/journal.pone.0147674 |
Ejemplares similares
-
Biostable ssDNA Aptamers Specific for Hodgkin Lymphoma
por: Parekh, Parag, et al.
Publicado: (2013) -
Acousto-microfluidics for screening of ssDNA aptamer
por: Park, Jee-Woong, et al.
Publicado: (2016) -
Selection and Identification of an ssDNA Aptamer for Fibroblast Activation Protein
por: Zhang, Xiaomin, et al.
Publicado: (2023) -
Screening and Identification of ssDNA Aptamer for Human GP73
por: Du, Jingchun, et al.
Publicado: (2015) -
Selection and targeting of EpCAM protein by ssDNA aptamer
por: Alshaer, Walhan, et al.
Publicado: (2017)